Study of Ublituximab for Ocrelizumab Wearing-Off in Multiple Sclerosis
Clinical trial NCT07389590 · RECRUITING
Trial details
- NCT number
- NCT07389590
- Sponsor
- Johns Hopkins University
- Status
- RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2026-02-10
- Primary completion
- 2028-10-01
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.